BLECH ISAAC 4
4 · Edge Therapeutics, Inc. · Filed Jun 21, 2018
Insider Transaction Report
Form 4
BLECH ISAAC
Director
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+20,000→ 20,000 totalExercise: $1.10→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.